OEMs, FDA Still At Odds Over Premarket Requirements For Reprocessed SUDs
This article was originally published in The Gray Sheet
Executive Summary
It appears unlikely that FDA will require all reprocessor submissions for single-use devices to support a "reusable" claim, despite opposing comments by Smith & Nephew and other original equipment manufacturers.
You may also be interested in...
Single-Use Device Reuse Needs Greater Federal Oversight - FDA, GAO
Manufacturers' inclusion of instructions for devices labeled for single-use on how to clean and reprocess the products would constitute a deceptive practice in the eyes of FDA, Center for Devices and Radiological Health Director David Feigal testified June 27.
Single-Use Device Reuse Needs Greater Federal Oversight - FDA, GAO
Manufacturers' inclusion of instructions for devices labeled for single-use on how to clean and reprocess the products would constitute a deceptive practice in the eyes of FDA, Center for Devices and Radiological Health Director David Feigal testified June 27.
Open-But-Unused SUD Reprocessing Will Not Be Pursued - FDA's Kessler
FDA expects to issue a final guidance by August on its approach to regulate reprocessing of single-use devices (SUDs) by third-party facilities, according to Larry Kessler, director of the Center for Devices and Radiological Health's Office of Surveillance and Biometrics.